Paraneoplastic thrombocytosis: the secrets of tumor self-promotion

Blood. 2014 Jul 10;124(2):184-7. doi: 10.1182/blood-2014-03-562538. Epub 2014 May 27.

Abstract

Paraneoplastic thrombocytosis is associated with many solid tumors and often correlates with reduced survival. Recent studies suggest that a pathogenic feed back loop may be operative between platelets and tumor cells, with reciprocal interactions between tumor growth/metastasis and thrombocytosis/platelet activation. Specific molecular pathways have been identified in which tumors can stimulate platelet production and activation; activated platelets can, in turn, promote tumor growth and metastasis. Taken together, these findings provide exciting new potential targets for therapeutic intervention.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use
  • Blood Platelets / pathology
  • Blood Platelets / physiology
  • Cell Proliferation
  • Humans
  • Molecular Targeted Therapy
  • Paraneoplastic Syndromes / drug therapy
  • Paraneoplastic Syndromes / etiology
  • Paraneoplastic Syndromes / pathology*
  • Thrombocytosis / drug therapy
  • Thrombocytosis / etiology
  • Thrombocytosis / pathology
  • Tumor Microenvironment / physiology

Substances

  • Antineoplastic Agents